Spots Global Cancer Trial Database for tebotelimab 3 mg
Every month we try and update this database with for tebotelimab 3 mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms | NCT03219268 | Advanced Solid ... Hematologic Neo... Ovarian Cancer HER2-positive A... Non Small Cell ... Small-cell Lung... Squamous Cell C... Cholangiocarcin... Cervical Cancer TNBC - Triple-N... | tebotelimab 1 m... tebotelimab 3 m... tebotelimab 10 ... tebotelimab 30 ... tebotelimab 120... tebotelimab 300... tebotelimab 400... tebotelimab 600... tebotelimab 800... tebotelimab 120... margetuximab | 18 Years - | MacroGenics |